Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - PROVECTUS BIOPHARMACEUTICALS, INC. | Financial_Report.xls |
| 10-K - FORM 10-K - PROVECTUS BIOPHARMACEUTICALS, INC. | d264546d10k.htm |
| EX-32 - SECTION 906 CEO AND CFO CERTIFICATION - PROVECTUS BIOPHARMACEUTICALS, INC. | d264546dex32.htm |
| EX-31.1 - SECTION 302 CEO CERTIFICATION - PROVECTUS BIOPHARMACEUTICALS, INC. | d264546dex311.htm |
| EX-31.2 - SECTION 302 CFO CERTIFICATION - PROVECTUS BIOPHARMACEUTICALS, INC. | d264546dex312.htm |
| EX-10.14 - EX-10.14 - PROVECTUS BIOPHARMACEUTICALS, INC. | d264546dex1014.htm |
| EX-10.13 - EX-10.13 - PROVECTUS BIOPHARMACEUTICALS, INC. | d264546dex1013.htm |
| EX-10.11 - EX-10.11 - PROVECTUS BIOPHARMACEUTICALS, INC. | d264546dex1011.htm |
| EX-10.12 - EX-10.12 - PROVECTUS BIOPHARMACEUTICALS, INC. | d264546dex1012.htm |
Exhibit 23
Consent of Independent Registered Public Accounting Firm
Provectus Pharmaceuticals, Inc.
Knoxville, Tennessee
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-167906 and 333-147783) of Provectus Pharmaceuticals, Inc. of our reports dated March 14, 2012 relating to the consolidated financial statements, and the effectiveness of Provectus Pharmaceuticals Inc.’s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP
Chicago, Illinois
March 14, 2012